CLINICAL_TRIALS
trial_result
· 2022-10-12
Clinical Trial Update: Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD) [Phase 2]
Summary
Phase 2 study evaluating EYP001a with nucleos(t)ide analogs in chronic hepatitis B; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Enyo Pharma | Conditions: Hepatitis B, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2022-10-12